A detailed history of American Portfolios Advisors transactions in Organon & Co. stock. As of the latest transaction made, American Portfolios Advisors holds 2,178 shares of OGN stock, worth $35,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,178
Holding current value
$35,044
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$23.4 - $34.25 $50,965 - $74,596
2,178 New
2,178 $51 Million
Q2 2022

Mar 20, 2023

SELL
$31.66 - $38.9 $9,118 - $11,203
-288 Reduced 13.22%
1,890 $63.8 Million
Q1 2022

Mar 21, 2023

SELL
$30.45 - $39.36 $2,770 - $3,581
-91 Reduced 4.18%
2,087 $72.9 Million
Q4 2021

Mar 21, 2023

BUY
$28.67 - $37.13 $6,508 - $8,428
227 Added 10.42%
2,405 $73.2 Million
Q3 2021

Mar 22, 2023

BUY
$28.63 - $35.64 $8,875 - $11,048
310 Added 14.23%
2,488 $81.6 Million
Q2 2021

Mar 22, 2023

BUY
$28.45 - $38.0 $4,438 - $5,928
156 Added 7.16%
2,334 $70.6 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.09B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.